Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lingdancao Granules for Seasonal Influenza
NCT02662426Phase 3Unknown
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Apr 2016
- Primary completion
- Nov 2017
- Modality
- Allosteric Modulators, Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of laggera pterodonta in seasonal influenza (3 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: The time needed for alleviation of all influenza symptoms up to 30 days. Status: unknown.
02
Drugs
laggera pterodonta
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on NCT02662426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02662426.